Santhera Pharmaceuticals Holding AG at Annual General Meeting held on 30 June 2022, shareholders elected Thomas Meier, PhD, as Chairman of the Board of Directors. As members of the Compensation Committee, the shareholders confirmed Patrick Vink and elected Thomas Meier, PhD. Elmar Schnee, Chairman of the Board and member of the Compensation Committee of Santhera since 2017, did not stand for re-election (as per amendment to the AGM invite).
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.17 CHF | -1.29% | -1.50% | -6.52% |
Apr. 25 | Transcript : Santhera Pharmaceuticals Holding AG, 2023 Earnings Call, Apr 25, 2024 | |
Apr. 25 | Santhera Pharmaceuticals Swings to Profit in FY23; Revenue Grows | MT |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-6.52% | 114M | |
+7.91% | 72.81B | |
+12.64% | 9.13B | |
-10.56% | 5.13B | |
+58.79% | 4.99B | |
+4.07% | 3.9B | |
-16.90% | 2.48B | |
-26.13% | 2.32B | |
+19.31% | 2.17B | |
-0.50% | 1.64B |
- Stock Market
- Equities
- SANN Stock
- News Santhera Pharmaceuticals Holding AG
- Santhera Pharmaceuticals Holding AG Announces Board Changes